Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
![health sceinces institute dr. allan spreen health sceinces institute dr. allan spreen](https://m.media-amazon.com/images/I/515pyj0D4VL._SL160_.jpg)
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,Įl Sahly, Hana M Baden, Lindsey R Essink, Brandon Doblecki-Lewis, Susanne Martin, Judith M Anderson, Evan J Campbell, Thomas B Clark, Jesse Jackson, Lisa A Fichtenbaum, Carl J Zervos, Marcus Rankin, Bruce Eder, Frank Feldman, Gregory Kennelly, Christina Han-Conrad, Laurie Levin, Michael Neuzil, Kathleen M Corey, Lawrence Gilbert, Peter Janes, Holly Follmann, Dean Marovich, Mary Polakowski, Laura Mascola, John R Ledgerwood, Julie E Graham, Barney S August, Allison Clouting, Heather Deng, Weiping Han, Shu Leav, Brett Manzo, Deb Pajon, Rolando Schödel, Florian Tomassini, Joanne E Zhou, Honghong Miller, Jacqueline 2021. Cardiovascular Risk and Health Among People With HIV Eligible for Primary Prevention: Insights From the REPRIEVE Trial. JAMA, 326 1, 46-55ĭouglas, Pamela S Umbleja, Triin Bloomfield, Gerald S Fichtenbaum, Carl J Zanni, Markella V Overton, Edgar T Fitch, Kathleen V Kileel, Emma M Aberg, Judith A Currier, Judith Sponseller, Craig A Melbourne, Kathleen Avihingsanon, Anchalee Bustorff, Flavio Estrada, Vicente Ruxrungtham, Kiat Saumoy, Maria Navar, Ann Marie Hoffmann, Udo Ribaudo, Heather J Grinspoon, Steven 2021. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. The New England journal of medicine, 384 5, 403-416Ĭohen, Myron S Nirula, Ajay Mulligan, Mark J Novak, Richard M Marovich, Mary Yen, Catherine Stemer, Alexander Mayer, Stockton M Wohl, David Brengle, Blair Montague, Brian T Frank, Ian McCulloh, Russell J Fichtenbaum, Carl J Lipson, Brad Gabra, Nashwa Ramirez, Julio A Thai, Christine Chege, Wairimu Gomez Lorenzo, Margarita M Sista, Nirupama Farrior, Jennifer Clement, Meredith E Brown, Elizabeth R Custer, Kenneth L Van Naarden, Jacob Adams, Andrew C Schade, Andrew E Dabora, Matan C Knorr, Jack Price, Karen L Sabo, Janelle Tuttle, Jay L Klekotka, Paul Shen, Lei Skovronsky, Daniel M 2021. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. Peer Reviewed Publicationsīaden, Lindsey R El Sahly, Hana M Essink, Brandon Kotloff, Karen Frey, Sharon Novak, Rick Diemert, David Spector, Stephen A Rouphael, Nadine Creech, C Buddy McGettigan, John Khetan, Shishir Segall, Nathan Solis, Joel Brosz, Adam Fierro, Carlos Schwartz, Howard Neuzil, Kathleen Corey, Larry Gilbert, Peter Janes, Holly Follmann, Dean Marovich, Mary Mascola, John Polakowski, Laura Ledgerwood, Julie Graham, Barney S Bennett, Hamilton Pajon, Rolando Knightly, Conor Leav, Brett Deng, Weiping Zhou, Honghong Han, Shu Ivarsson, Melanie Miller, Jacqueline Zaks, Tal 2021. His published works include approximately more than 100 articles, 75 abstracts and various reviews, book chapters and letters. Fichtenbaum has been elected as a Fellow to the American College of Physicians, HIV Medical Association, and Infectious Diseases Society of America.
![health sceinces institute dr. allan spreen health sceinces institute dr. allan spreen](https://journals.openedition.org/ejas/docannexe/image/14654/img-2.png)
He is board certified by the American Board of Internal Medicine and Infectious Diseases. He is Principal Investigator of Sexually Transmitted Infections Grant. Fichtenbaum is Principal Investigator of the AIDS Clinical Trials Unit at UC.
![health sceinces institute dr. allan spreen health sceinces institute dr. allan spreen](https://journals.openedition.org/ejas/docannexe/image/14654/img-1.png)
Fichtenbaum's expertise is in clinical research in infectious diseases, in particular complications of HIV, antiretroviral therapy, dyslipidemia and cardiovascular disease. HIV/AIDS (Human immunodeficiency virus) Summaryĭr.